NHS England » Hundreds of thousands of women access free morning-after pill at NHS pharmacies in first 5 months ...

Fampridine is the first medicine designed to improve walking in adults with MS and will now be routinely available on the NHS from today, NHS England has announced. Taken as a pill twice a day, ...

NHS England » NHS Excellence Awards 2026 The awards recognised teams that found better ways to meet some of the NHS’s biggest challenges. These case studies show the different approaches they took and ...

Medway’s treatment for patients in their own homes saves almost 5,000 bed days. Medway Foundation Trust built the multi-specialty Medway SMART Acute Virtual Hospital providing acute-level care in ...

Pilot hubs in Lambeth, Greenwich and Bexley cut waiting times and improve access to women’s and girls’ health services. South East London Integrated Care Board launched 2 co-designed women’s and girls ...

When you go for your vaccinations, staff may ask which of these groups you are in. Please have your offer of a college or university place with you to show them. How to get your vaccinations Two doses ...

The NHS is facing a “summer onslaught”, with A&Es experiencing their busiest month on record in June amid record heatwaves and the World Cup. Average daily A&E attendances exceeded 80,000 (81,264) for ...

The head of the NHS has today issued a stark warning to staff that they face the sack or even prison if they access patient records without a legitimate reason, as part of a new crackdown by the ...

Patients are to receive at least 3 weeks’ notice from the NHS for all new planned medical appointments, under plans to overhaul patients’ experiences of the health service. NHS Chief Executive, Sir ...

The NHS has hit its target for the number of patients waiting 18-weeks thanks to the biggest improvement in waiting times since the launch of the iPad. In March, 65.3% of patients were waiting ...

Neighbourhood health centres (NHCs) support the NHS shift towards prevention, early intervention and more integrated care delivered closer to home. The Neighbourhood health centre guidance for regions ...

A new life-changing treatment option – GLP-1 drug semaglutide known as Wegovy – is set to be available on the NHS within months, with 1.2 million people with cardiovascular disease eligible to receive ...